The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review

被引:51
作者
Atton, Giles [1 ]
Gordon, Kristiana [2 ]
Brice, Glen [1 ,2 ]
Keeley, Vaughan [3 ]
Riches, Katie [3 ]
Ostergaard, Pia [4 ]
Mortimer, Peter [4 ]
Mansour, Sahar [1 ]
机构
[1] St Georges Healthcare NHS Trust, South West Thames Reg Genet Serv, London SW17 0RE, England
[2] St Georges Hosp NHS Trust, Dept Dermatol, London, England
[3] Derby Hosp Fdn NHS Trust, Lymphoedema Clin, Derby, England
[4] Univ London, Div Cardiovasc & Cell Sci, Lymphovasc Res Unit, London, England
关键词
MILROY DISEASE; XP DELETIONS; LYMPHEDEMA; DIAGNOSIS;
D O I
10.1038/ejhg.2015.41
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Turner syndrome is a complex disorder caused by an absent or abnormal sex chromosome. It affects 1/2000-1/3000 live-born females. Congenital lymphoedema of the hands, feet and neck region (present in over 60% of patients) is a common and key diagnostic indicator, although is poorly described in the literature. The aim of this study was to analyse the medical records of a cohort of 19 Turner syndrome patients attending three specialist primary lymphoedema clinics, to elucidate the key features of the lymphatic phenotype and provide vital insights into its diagnosis, natural history and management. The majority of patients presented at birth with four-limb lymphoedema, which often resolved in early childhood, but frequently recurred in later life. The swelling was confined to the legs and hands with no facial or genital swelling. There was only one case of suspected systemic involvement (intestinal lymphangiectasia). The lymphoscintigraphy results suggest that the lymphatic phenotype of Turner syndrome may be due to a failure of initial lymphatic (capillary) function.
引用
收藏
页码:1634 / 1639
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2006, BEST PRACTICE MANAGE
[2]  
Bellini C, 2009, LYMPHOLOGY, V42, P123
[3]   Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location [J].
Boucher, CA ;
Sargent, CA ;
Ogata, T ;
Affara, NA .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (09) :591-598
[4]   Milroy disease and the VEGFR-3 mutation phenotype [J].
Brice, G ;
Child, AH ;
Evans, A ;
Bell, R ;
Mansour, S ;
Burnand, K ;
Sarfarazi, M ;
Jeffery, S ;
Mortimer, P .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (02) :98-102
[5]  
CANKI N, 1988, ANN GENET-PARIS, V31, P4
[6]   The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings [J].
Connell, F. C. ;
Gordon, K. ;
Brice, G. ;
Keeley, V. ;
Jeffery, S. ;
Mortimer, P. S. ;
Mansour, S. ;
Ostergaard, P. .
CLINICAL GENETICS, 2013, 84 (04) :303-314
[7]   Turner's syndrome in adulthood [J].
Elsheikh, M ;
Dunger, DB ;
Conway, GS ;
Wass, JAH .
ENDOCRINE REVIEWS, 2002, 23 (01) :120-140
[8]   FLT4/VEGFR3 and Milroy Disease: Novel Mutations, a Review of Published Variants and Database Update [J].
Gordon, Kristiana ;
Spiden, Sarah L. ;
Connell, Fiona C. ;
Brice, Glen ;
Cottrell, Sally ;
Short, John ;
Taylor, Rohan ;
Jeffery, Steve ;
Mortimer, Peter S. ;
Mansour, Sahar ;
Ostergaard, Pia .
HUMAN MUTATION, 2013, 34 (01) :23-31
[9]  
Gunther DF., 2006, Int Congr Ser, V1298, P58, DOI [10.1016/j.ics.2006.06.001, DOI 10.1016/J.ICS.2006.06.001]
[10]  
Keeley V., 2006, J LYMPHOEDEMA, V1, P42